Found: 3
Select item for more details and to access through your institution.
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis.
- Published in:
- EMBO Molecular Medicine, 2024, v. 16, n. 4, p. 966, doi. 10.1038/s44321-024-00043-z
- By:
- Publication type:
- Article
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity.
- Published in:
- Science Immunology, 2024, v. 9, n. 95, p. 1, doi. 10.1126/sciimmunol.adj9730
- By:
- Publication type:
- Article
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-022-01278-3
- By:
- Publication type:
- Article